Christopher Larminie

2.5k total citations
15 papers, 741 citations indexed

About

Christopher Larminie is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Christopher Larminie has authored 15 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Christopher Larminie's work include RNA Research and Splicing (3 papers), Genomics and Chromatin Dynamics (3 papers) and Single-cell and spatial transcriptomics (2 papers). Christopher Larminie is often cited by papers focused on RNA Research and Splicing (3 papers), Genomics and Chromatin Dynamics (3 papers) and Single-cell and spatial transcriptomics (2 papers). Christopher Larminie collaborates with scholars based in United Kingdom, United States and Sweden. Christopher Larminie's co-authors include Iain L. Johnstone, Robert J. White, Paul R. Murdock, Malcolm Duckworth, Mark A. Scheideler, Jean‐Philippe Walhin, Martine Garnier, Kendall Blumer, Jorge Esparza-Gordillo and Paola G. Bronson and has published in prestigious journals such as Nature Communications, Nature Genetics and The EMBO Journal.

In The Last Decade

Christopher Larminie

15 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Larminie United Kingdom 11 493 148 127 103 67 15 741
Jiajia Feng China 13 427 0.9× 114 0.8× 71 0.6× 106 1.0× 62 0.9× 39 902
Juan C. Perín United States 14 510 1.0× 111 0.8× 189 1.5× 50 0.5× 40 0.6× 17 834
Turan Tufan United States 11 483 1.0× 61 0.4× 120 0.9× 63 0.6× 28 0.4× 17 611
Andrew Knights United Kingdom 10 625 1.3× 125 0.8× 229 1.8× 47 0.5× 65 1.0× 12 915
Barbara Herdy Austria 10 853 1.7× 67 0.5× 76 0.6× 38 0.4× 125 1.9× 12 1.0k
Seema B. Plaisier United States 7 513 1.0× 157 1.1× 111 0.9× 98 1.0× 38 0.6× 10 906
Elaine Pirie United States 10 438 0.9× 117 0.8× 48 0.4× 50 0.5× 99 1.5× 14 723
Jingwen Yin China 15 774 1.6× 92 0.6× 124 1.0× 58 0.6× 47 0.7× 49 1.2k
Łukasz P. Słomnicki United States 13 538 1.1× 200 1.4× 62 0.5× 114 1.1× 68 1.0× 19 837
Paweł Stocki United Kingdom 15 423 0.9× 117 0.8× 48 0.4× 63 0.6× 27 0.4× 22 649

Countries citing papers authored by Christopher Larminie

Since Specialization
Citations

This map shows the geographic impact of Christopher Larminie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Larminie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Larminie more than expected).

Fields of papers citing papers by Christopher Larminie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Larminie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Larminie. The network helps show where Christopher Larminie may publish in the future.

Co-authorship network of co-authors of Christopher Larminie

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Larminie. A scholar is included among the top collaborators of Christopher Larminie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Larminie. Christopher Larminie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cano-Gamez, Eddie, Blagoje Soskic, Theodoros I. Roumeliotis, et al.. (2020). Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4+ T cells to cytokines. Nature Communications. 11(1). 1801–1801. 145 indexed citations
2.
Soskic, Blagoje, Eddie Cano-Gamez, Deborah J. Smyth, et al.. (2019). Chromatin activity at GWAS loci identifies T cell states driving complex immune diseases. Nature Genetics. 51(10). 1486–1493. 63 indexed citations
3.
Evans, Stephanie, Kieran Alden, L. Cucurull-Sanchez, et al.. (2017). ASPASIA: A toolkit for evaluating the effects of biological interventions on SBML model behaviour. PLoS Computational Biology. 13(2). e1005351–e1005351. 4 indexed citations
4.
Wilson, Paul A., Christopher Larminie, & Rona Smith. (2017). Literature mining, gene-set enrichment and pathway analysis for target identification in Behçet's disease.. PubMed. 34(6 Suppl 102). 101–110. 4 indexed citations
5.
Betts, Joanna, Ruth J. Mayer, Ruth Tal‐Singer, et al.. (2014). Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo‐controlled clinical trial. Pharmacology Research & Perspectives. 3(1). e00094–e00094. 16 indexed citations
6.
Harland, Lee, Christopher Larminie, Susanna‐Assunta Sansone, et al.. (2011). Empowering industrial research with shared biomedical vocabularies. Drug Discovery Today. 16(21-22). 940–947. 11 indexed citations
7.
Lora, José M., David M. Wilson, Kevin Lee, & Christopher Larminie. (2010). Epigenetic control of the immune system: histone demethylation as a target for drug discovery. Drug Discovery Today Technologies. 7(1). e67–e75. 5 indexed citations
8.
Maycox, Peter R., F. M. Kelly, Adam Taylor, et al.. (2009). Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Molecular Psychiatry. 14(12). 1083–1094. 150 indexed citations
9.
Thomas, David R., et al.. (2004). Cloning and pharmacological characterisation of the guinea pig 5-ht5A receptor. European Journal of Pharmacology. 494(2-3). 91–99. 16 indexed citations
10.
Larminie, Christopher, Paul R. Murdock, Jean‐Philippe Walhin, et al.. (2004). Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Molecular Brain Research. 122(1). 24–34. 114 indexed citations
11.
Larminie, Christopher, Josephine E. Sutcliffe, Kerrie Tosh, et al.. (1999). Activation of RNA Polymerase III Transcription in Cells Transformed by Simian Virus 40. Molecular and Cellular Biology. 19(7). 4927–4934. 41 indexed citations
12.
Larminie, Christopher, Hadi M. Alzuherri, Carol Cairns, Angela McLees, & Robert J. White. (1998). Transcription by RNA polymerases I and III: a potential link between cell growth, protein synthesis and the retinoblastoma protein. Journal of Molecular Medicine. 76(2). 94–103. 30 indexed citations
13.
Larminie, Christopher & Robert J. White. (1998). Identification of a Putative BRF Homologue in the Genome of Caenorhabditis elegans. DNA sequence. 9(1). 49–58. 6 indexed citations
14.
Larminie, Christopher. (1997). Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. The EMBO Journal. 16(8). 2061–2071. 86 indexed citations
15.
Larminie, Christopher & Iain L. Johnstone. (1996). Isolation and Characterization of Four Developmentally Regulated Cathepsin B-Like Cysteine Protease Genes from the Nematode Caenorhabditis elegans. DNA and Cell Biology. 15(1). 75–82. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026